Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 877 across all filing types
Latest filing 2015-04-01 Regulatory Filings
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical erhåller ytterligare patent i USA
Regulatory Filings Classification · 95% confidence The document is a 'Pressmeddelande' (Press Release) dated April 1, 2015, announcing that Episurf Medical has received notification that its patent application for a 'Surgical kit for cartilage injury repair' will be approved for registration in the USA on April 14, 2015. This announcement concerns intellectual property (a patent grant) and is a specific corporate update, not a comprehensive financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). Since there is no specific category for 'Patent Grant Announcement,' and it is a formal corporate communication regarding a significant business development (IP protection), it best fits the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory/corporate announcement, although 'LTR' (Legal Proceedings Report) is sometimes used for IP matters, RNS is a safer general fallback for non-financial, non-management specific announcements.
2015-04-01 Swedish
Annual Report 2014
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning 2014' (Annual Report 2014) for Episurf Medical. It contains a comprehensive table of contents covering business strategy, market overview, management report (Förvaltningsberättelse), financial statements (Räkenskaper), notes (Noter), and the auditor's report (Revisionsberättelse). The document length and structure confirm it is the full annual report for the fiscal year 2014. FY 2014
2015-04-01 Swedish
Ny fördelning av A- och B-aktier
Share Issue/Capital Change Classification · 98% confidence The document is a press release from Episurf Medical AB dated March 31, 2015. The core content announces a 'Ny fördelning av A- och B-aktier' (New distribution of A and B shares) due to conversions between share classes. This directly relates to a change in the company's capital structure (share classes and total count). This aligns precisely with the definition for 'Share Issue/Capital Change' (Code: SHA), which covers changes in capital structure, including share class adjustments. It is not an earnings release, a dividend notice, or a general regulatory filing (RNS), as it concerns a specific capital structure event.
2015-03-31 Swedish
Belgisk patient återställd efter Episurf-operation - 1 årsberättelse
Environmental & Social Information Classification · 99% confidence The document is a press release dated March 26, 2015, titled "Belgisk patient återställd efter Episurf-operation - 1 årsberättelse" (Belgian patient recovered after Episurf operation - 1-year report). It details a patient success story and includes commentary from a Medical Advisor, concluding with standard company information and a statement about public disclosure requirements under securities laws. This format—a press release announcing positive operational/medical outcomes and patient testimonials—does not fit the strict definitions of 10-K, ER, IR, or AR. It is not a formal financial report, a management discussion, or a proxy statement. Since it is a specific announcement (a patient story/case study release) that doesn't fit the other specific categories (like DIRS, DIV, CAP, etc.), the most appropriate general category for a non-standard regulatory announcement or press release that doesn't fit elsewhere is Regulatory Filings (RNS). However, given the content is a patient testimonial and medical update, it is often categorized as Investor Relations material, but RNS serves as the best catch-all for press releases not explicitly covered.
2015-03-26 Swedish
Episurf Medical lanserar betaversion av första tjänsten inom Episurf Support Services och ny webbsida
Regulatory Filings Classification · 95% confidence The document is explicitly labeled as a "Pressmeddelande" (Press Release) dated March 25, 2015. It announces the launch of a beta version of a new service ('Lite Assessment') and a new corporate website/graphic profile. This type of announcement, detailing strategic business updates, new service rollouts, and branding changes, is generally classified as a general regulatory announcement or news release that doesn't fit the strict definitions of financial reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, DIRS). Since it is a general, time-sensitive announcement from a publicly listed company, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements not covered by more specific codes.
2015-03-25 Swedish
Första operationerna i Storbritannien genomförda med önskat resultat
Regulatory Filings Classification · 95% confidence The document is a press release dated March 19, 2015, announcing that the first operations using the Episealer® Femoral Condyle implant were successfully performed in the UK. It details the procedure, quotes a surgeon, and mentions this is part of a controlled product launch (CPL) in the eighth country. This type of announcement, detailing operational milestones, product usage, and market expansion, is typically classified as a general regulatory announcement or news release that doesn't fit the specific financial report categories (like 10-K, ER, or IR). Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general, non-financial-result-focused press release, although it could also be considered a form of 'Investor Presentation' (IP) material if it were a formal presentation. However, as a standard press release about operational progress, RNS is the best fit among the provided codes, as it is a general regulatory announcement.
2015-03-19 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.